Organon And Henlius Complete Phase III For Denosumab

Pair’s HLX14 Partnered Biosimilar Rival To Prolia/Xgeva Meets Primary Endpoints

 
• By David Wallace
Clinical trial puzzle
HLX14 has met primary endpoints in a Phase III trial • Source: Shutterstock

More from Biosimilars

More from Products